Company / Gross Profit per Share
Quest Diagnostics Gross Profit per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$26.14
FY2020
5-year range
-
FY2016-FY2020
Trend
+40.5%
vs FY2019
Sector context
#14 of 99
Health Care
What the data says
Quest Diagnostics's gross profit per share of $26.14 is higher than 86% of companies in the Health Care sector (FY2020). Gross Profit per Share returned to growth in FY2020 after 2 years of decline, reaching $26.14.
Based on SEC 10-K filings.
26.14 in FY2020 with a 3-year CAGR of +9.3%. Top quartile in the Health Care sector.
Improved from $18.89 to $26.14 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+89.2% above sector average
Key checks
Key Insights
- In FY2020, gross profit per share increased 40.5% year-over-year.
- Ranks #14 out of 99 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $26.14 | +40.5% |
| FY2019 | $18.61 | -1.5% |
| FY2018 | $18.89 | -5.5% |
| FY2017 | $19.99 | +2.2% |
| FY2016 | $19.56 | +7.0% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026